Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania
- 31 December 2007
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 100, S45-S53
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorderJournal of Affective Disorders, 2007
- Symptomatic Remission in Patients With Bipolar ManiaThe Journal of Clinical Psychiatry, 2005
- A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II DepressionAmerican Journal of Psychiatry, 2005
- A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar DisorderThe Journal of Clinical Psychiatry, 2005
- Recovery and functional outcomes following olanzapine treatment for bipolar I maniaBipolar Disorders, 2005
- Rapid Antimanic Effect of Risperidone Monotherapy: A 3-Week Multicenter, Double-Blind, Placebo-Controlled TrialAmerican Journal of Psychiatry, 2004
- A Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of Aripiprazole in Patients With Acute Bipolar ManiaAmerican Journal of Psychiatry, 2003
- Rates of response, euthymia and remission in two placebo‐controlled olanzapine trials for bipolar maniaBipolar Disorders, 2003
- A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I DepressionThe Journal of Clinical Psychiatry, 1999
- Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group1994